Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 4 papers. Top paper: “Efficacy and safety of selumetinib in adults with neurofibromatosis type 1 and symptomatic, inoperable plexiform neurofibromas (KOMET): a multicentre, international, randomised, placebo-controlled, parallel, double-blind, phase 3 study”.
Geraldine O’Sullivan Coyne, Pamela L. Wolters, Staci Martin, Said Farschtschi, Ignacio Blanco +38 more
Stanley M. Tahara, Hidekazu Tsukamoto, Keigo Machida, Yicheng Zhu
Lulu Sun, Xiaomin Hu, Xuemei Wang, Feng Xu, Bo Chen +14 more
Yicheng Zhu, Xuyao Zhao, S.N. Mehta, Juan Carlos Hernandez, Jae Jin Lee +11 more